Literature DB >> 26318593

Depressive Symptoms Clusters and Insulin Resistance: Race/Ethnicity as a Moderator in 2005-2010 NHANES Data.

Elizabeth A Vrany1, Jessica M Berntson1, Tasneem Khambaty1, Jesse C Stewart2.   

Abstract

BACKGROUND: Although depression has been linked to insulin resistance, few studies have examined depressive symptom clusters.
PURPOSE: We examined whether certain depressive symptom clusters are more strongly associated with insulin resistance in a nationally representative sample, and we evaluated potential moderators and mediators.
METHODS: Respondents were 4487 adults from NHANES 2005-2010. Depressive symptoms were measured with the Patient Health Questionnaire-9 (PHQ-9), and insulin resistance was indexed by the homeostatic model assessment (HOMA) score.
RESULTS: Positive relationships between PHQ-9 total, somatic, and cognitive-affective scores and HOMA score were detected (ps <0.001). In a simultaneous model, the somatic (p = 0.017), but not the cognitive-affective (p = 0.071), score remained associated with HOMA score. We observed evidence of (a) moderation by race/ethnicity (relationships stronger in non-Hispanic Whites) and (b) mediation by body mass and inflammation.
CONCLUSIONS: The depressive symptoms-insulin resistance link may be strongest among non-Hispanic Whites and may be driven slightly more by the somatic symptoms.

Entities:  

Keywords:  Depression; Depressive symptom clusters; Diabetes; Insulin resistance; NHANES; Race/ethnicity

Mesh:

Year:  2016        PMID: 26318593     DOI: 10.1007/s12160-015-9725-0

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  9 in total

1.  Measurement invariance of the patient health questionnaire-9 (PHQ-9) depression screener in U.S. adults across sex, race/ethnicity, and education level: NHANES 2005-2016.

Authors:  Jay S Patel; Youngha Oh; Kevin L Rand; Wei Wu; Melissa A Cyders; Kurt Kroenke; Jesse C Stewart
Journal:  Depress Anxiety       Date:  2019-07-29       Impact factor: 6.505

2.  Depressive Disorder Subtypes as Predictors of Incident Obesity in US Adults: Moderation by Race/Ethnicity.

Authors:  Brittanny M Polanka; Elizabeth A Vrany; Jay Patel; Jesse C Stewart
Journal:  Am J Epidemiol       Date:  2017-05-01       Impact factor: 4.897

3.  Associations of somatic depressive symptoms with body mass index, systemic inflammation, and insulin resistance in primary care patients with depression.

Authors:  Aubrey L Shell; Michelle K Williams; Jay S Patel; Elizabeth A Vrany; Robert V Considine; Anthony J Acton; Jesse C Stewart
Journal:  J Behav Med       Date:  2022-09-08

4.  Systemic Inflammation in Midlife: Race, Socioeconomic Status, and Perceived Discrimination.

Authors:  Irena Stepanikova; Lori Brand Bateman; Gabriela R Oates
Journal:  Am J Prev Med       Date:  2017-01       Impact factor: 5.043

5.  Chronic Medical Conditions and Negative Affect; Racial Variation in Reciprocal Associations Over Time.

Authors:  Shervin Assari; Maryam Moghani Lankarani
Journal:  Front Psychiatry       Date:  2016-08-24       Impact factor: 4.157

6.  Reciprocal Associations between Depressive Symptoms and Mastery among Older Adults; Black-White Differences.

Authors:  Shervin Assari; Maryam M Lankarani
Journal:  Front Aging Neurosci       Date:  2017-01-05       Impact factor: 5.750

7.  The Link between Mastery and Depression among Black Adolescents; Ethnic and Gender Differences.

Authors:  Shervin Assari; Cleopatra Howard Caldwell
Journal:  Behav Sci (Basel)       Date:  2017-05-12

8.  Factor Structures of Patient Health Questionnaire-9 Instruments in Exploring Depressive Symptoms of Suburban Population.

Authors:  Linh Gia Vu; Linh Khanh Le; Anh Vu Trong Dam; Son Hoang Nguyen; Thuc Thi Minh Vu; Trang Thu Hong Trinh; Anh Linh Do; Ngoc Minh Do; Trang Huyen Le; Carl Latkin; Roger C M Ho; Cyrus S H Ho
Journal:  Front Psychiatry       Date:  2022-08-03       Impact factor: 5.435

9.  Depression and cardiovascular risk-association among Beck Depression Inventory, PCSK9 levels and insulin resistance.

Authors:  C Macchi; C Favero; A Ceresa; L Vigna; D M Conti; A C Pesatori; G Racagni; A Corsini; N Ferri; C R Sirtori; M Buoli; V Bollati; M Ruscica
Journal:  Cardiovasc Diabetol       Date:  2020-11-03       Impact factor: 8.949

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.